Fertility sparing treatments are of interest for women of child-bearing age (upto 45 years) with any gynecologic cancers including ovarian cancer, cervical cancer & endometrial cancer. These patients are reffered to oncofertility specialist for a consultation. Considering the medical and fertility history, age and suppression medicines, the oncologist and oncofertility specialists plan treatments which are either conservative or traditional. It is possible to spare fertility by conservative surgery in case the cancer is found at an early stage. This surgery generally includes removal of the ovary and fallopian tube of the affected side.
Fertility-sparing surgery (FSS) is indicated for patients with stage 1 epithelial ovarian cancer. FSS has proven efficacy in preserving fertility without apparent adverse impact on cancer outcomes. Advances in Assisted Reproductive Technologies (ART) have provided patients with more fertility options. Fertility preservation options such as ovarian tissue or oocyte retrival & storage is recommended for young women as the survival rates continue to improve.